Shu Y, Yu Y, Ji Y, Zhang L, et al. Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20-45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clinical trial. Vaccine 2022 Oct 22. pii: S0264-410X(22)01281.
PMID: 36283897